ISPOR SPONSORING SESSION AT DIA 2016 THIS JUNE

Published Apr 5, 2016
ANNOUNCEMENT

SOCIETY’S PRESIDENT-ELECT, LOU GARRISON, LEADING WORKSHOP

Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is attending and contributing to the Drug Information Association (DIA) Annual Meeting being held June 26-30, 2016 in Philadelphia, PA, USA.  ISPOR will be sponsoring a preconference workshop on Sunday, June 26 at DIA 2016. ISPOR President-Elect Lou Garrison, PhD will be one of the instructors for the half-day session entitled, The Evolving Role of Payers in Drug Development: Pricing, Pharmacoeconomics, and Health Technology Assessment. ISPOR is offering this preconference tutorial at this event to provide expanded access to educational resources as part of its mission to promote health economics and outcomes research (HEOR) excellence to improve decision making for health globally. For additional information, please contact Betsy Lane, director, chief marketing and communications officer at BLane@ispor.org or 609-586-4981 x112.

###

Related Stories

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Launches “HEOR Explained” Microsite

Dec 10, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has launched a new microsite—HEOR Explained—designed to help people better understand how health economics and outcomes research (HEOR) can improve healthcare decisions.

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×